Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy

被引:38
作者
Baslaim, MM
Al Malik, OA
Al-Sobhi, SS
Ibrahim, E
Ezzat, A
Ajarim, D
Tulbah, A
Chaudhary, MA
Sorbris, RA
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia
[2] King Fahad Cent Hosp, Dept Surg, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia
关键词
axillary lymph node retrieval; neoadjuvant chemotherapy; locally advanced breast cancer;
D O I
10.1016/S0002-9610(02)00959-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The purpose of this study was to assess our clinical impression that fewer lymph nodes are retrieved after level I and H axillary dissection after neoadjuvant chemotherapy and whether there is a positive correlation between the total number of lymph nodes retrieved and the number of diseased lymph nodes. Methods: Patients included those with stage IIB, IIIA, and IIIB breast cancer of whom 77 had neoadjuvant chemotherapy and 58 had initial surgery only. All had modified radical mastectomy with in continuity level I and II axillary dissection. Results: Patients after neoadjuvant chemotherapy had 14.3 +/- 6.7 lymph nodes detected versus 16.9 +/- 8.8 (mean +/- SD; P < 0.057) for those with initial surgery only. The number of positive nodes were 3.7 +/- 4.7 versus 6.6 +/- 8.7 (mean +/- SD; P < 0.033) respectively and the number of negative nodes were 10.6 +/- 7.5 versus 10.4 +/- 8 (mean +/- SD; P < 0.9). The correlation between the number of positive lymph nodes and the total number of lymph nodes was r = 0.58; P < 0.001. Conclusions: It appears that fewer lymph nodes are retrieved after level I and II axillary dissection after neoadjuvant chemotherapy. The total number of lymph nodes retrieved increases directly with the number of positive lymph nodes in patients not treated with chemotherapy. (C) 2002 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:299 / 301
页数:3
相关论文
共 9 条
[1]   An overview of breast cancer [J].
Ezzat, A ;
Raja, M ;
Rostom, A ;
Zwaan, F ;
Akhtar, M ;
Bazarbashi, S ;
Ingemansson, S ;
AlAbdulkareem, A .
ANNALS OF SAUDI MEDICINE, 1997, 17 (01) :10-15
[2]   High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin [J].
Ezzat, AA ;
Ibrahim, EM ;
Ajarim, DS ;
Rahal, MM ;
Raja, MA ;
Stuart, RK ;
Tulbah, AM ;
Kandil, A ;
Al-Malik, OA ;
Bazarbashi, SM .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (03) :237-244
[3]   Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer [J].
Honkoop, AH ;
Pinedo, HM ;
DeJong, JS ;
Verheul, HMW ;
Linn, SC ;
Hoekman, K ;
Wagstaff, J ;
VanDiest, PJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (02) :211-218
[4]  
Kuerer H M, 2001, Breast Dis, V12, P69
[5]   Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy [J].
Kuerer, HM ;
Newman, LA ;
Smith, TL ;
Ames, FC ;
Hunt, KK ;
Dhingra, K ;
Theriault, RL ;
Singh, G ;
Binkley, SM ;
Sneige, N ;
Buchholz, TA ;
Ross, MI ;
McNeese, MD ;
Buzdar, AU ;
Hortobagyi, GN ;
Singletary, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :460-469
[6]   Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer [J].
Kuerer, HM ;
Newman, LA ;
Buzdar, AU ;
Hunt, KK ;
Dhingra, K ;
Buchholz, TA ;
Binkley, SM ;
Ames, FC ;
Feig, BW ;
Ross, MI ;
Hortobagyi, GN ;
Singletary, SE .
AMERICAN JOURNAL OF SURGERY, 1998, 176 (06) :502-508
[7]   Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer [J].
Kuerer, HM ;
Newman, LA ;
Fornage, BD ;
Dhingra, K ;
Hunt, KK ;
Buzdar, AU ;
Ames, FC ;
Ross, MI ;
Feig, BW ;
Hortobagyi, GN ;
Singletary, SE .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (08) :673-680
[8]  
PETREK JA, 1995, CURR PROB SURG, V32, P259
[9]   Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance [J].
Sneige, N ;
Kemp, B ;
Pusztai, L ;
Asmar, L ;
Hortobagyi, GN .
BREAST, 2001, 10 (06) :492-500